Mode
Text Size
Log in / Sign up

Postmenopausal Osteoporosis

Part of Osteoporosis

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Postmenopausal Osteoporosis

60 trials tracked for Postmenopausal Osteoporosis: 41 in phase 3 or 4 and 13 with published results. The most-cited published study has 579 citations.

60Trials tracked
41Phase 3 & 4
0Recruiting
13With published results
Phase distribution
Phase 4 14 Phase 3 27 Phase 2 8 Phase 1 5 Other / NA 6
  1. Phase 4 VERtebral Fracture Treatment Comparisons in Osteoporotic Women Completed · 579 cited
  2. Phase 3 An Open-label Study to Evaluate the Effect of Treatment With Romosozumab or Teriparatide in Postmenopausal Women Completed · 463 cited
  3. Phase 3 Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis Completed · 201 cited
  4. Phase 3 Efficacy and Safety of Romosozumab Treatment in Postmenopausal Women With Osteoporosis Completed · 163 cited
  5. Phase 4 Alterations of GCF Levels of Sclerostin and DKK-1 in Postmenopausal Osteoporosis Completed · 161 cited
  6. Phase 4 Denosumab and Teriparatide Study (DATA-HD and DATA-EX) Completed · 69 cited
Show 44 more trials
  1. Phase 3 Study to Evaluate the Safety and Efficacy of BA058 (Abaloparatide) for Prevention of Fracture in Postmenopausal Women Completed · 47 cited
  2. Phase 3 Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption Completed · 40 cited
  3. Phase 3 A Safety and Efficacy Study to Evaluate Romosozumab (AMG 785) in South Korean Women With Osteoporosis Completed · 28 cited
  4. Phase 3 Efficacy & Safety of Abaloparatide-Solid Microstructured Transdermal System in Postmenopausal Women With Osteoporosis Completed · 21 cited
  5. Phase 3 A Study to Compare SB16 (Proposed Denosumab Biosimilar) to Prolia® in Postmenopausal Women With Osteoporosis Completed · 12 cited
  6. Phase 4 Acute Effect of Teriparatide With Bisphosphonate or Denosumab on Bone Resorption Completed · 8 cited
  7. Phase 3 Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND Completed · 3 cited
  8. Phase 4 A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis. Completed
  9. Phase 4 A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP) Completed
  10. Phase 4 The Effects of Potassium Citrate on Bone Metabolism Completed
  11. Phase 4 Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis Completed
  12. Phase 4 Bone Modeling Effects of Combined Anabolic/Antiresorptive Administration Completed
  13. Phase 4 Zoledronic Acid for Osteoporotic Fracture Prevention (ZEST II) Completed
  14. Phase 4 Preventing Osteoporosis Using Denosumab Completed
  15. Phase 4 A Study Using Imaging Technology to Measure Changes in Bone Structure After Treatment With Teriparatide Completed
  16. Phase 4 Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263) Completed
  17. Phase 4 A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) Completed
  18. Phase 3 Denosumab China Phase III Study Completed
  19. Phase 3 A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis Completed
  20. Phase 3 A Randomized Phase 3 Study to Evaluate Two Formulations of Romosozumab in Postmenopausal Women With Osteoporosis Completed
  21. Phase 3 A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis Completed
  22. Phase 3 Comparative Efficacy and Safety Study of RGB-14-P and Prolia® in Women With Postmenopausal Osteoporosis Completed
  23. Phase 3 A Study to Evaluate the Efficacy, Pharmacodynamics, Safety, and Immunogenicity of FKS518 in Postmenopausal Women With Osteoporosis Completed
  24. Phase 3 A Phase 3 Study to Compare Biosimilar Denosumab With Prolia® Completed
  25. Phase 3 A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab Completed
  26. Phase 3 Study to Evaluate AMG 162 in the Prevention of Postmenopausal Osteoporosis Completed
  27. Phase 3 A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women Completed
  28. Phase 3 A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates Completed
  29. Phase 3 A Study of Monthly Risedronate for Osteoporosis Completed
  30. Phase 3 A Study in Indian Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab Completed
  31. Phase 3 Efficacy and Safety Study on Menatetrenone in the Treatment of Postmenopausal Osteoporosis Women Completed
  32. Phase 3 Study of Transitioning From Alendronate to Denosumab Completed
  33. Phase 3 A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab Completed
  34. Phase 3 Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis Completed
  35. Phase 3 A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis Completed
  36. Phase 2 Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women Completed
  37. Phase 2 Efficacy and Safety of Odanacatib (MK-0822) in Participants With Involutional Osteoporosis (MK-0822-022) Completed
  38. Phase 2 Delayed Release (DR) Risedronate Compared to Immediate Release (IR) in Postmenopausal Women Completed
  39. Phase 2 A Multicenter, Randomized Placebo Controlled Pilot MicroCT Study to Estimate the Effect of Treatment With Denosumab (AMG 162) and Alendronate Sodium in Postmenopausal Women With Low Bone Mineral Density Completed
  40. Phase 2 MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012) Completed
  41. Phase 2 Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density Completed
  42. Phase 2 Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of PTH Analog Tablets in Postmenopausal Women Completed
  43. Phase 2 A Transiliac Crest Bone Histology and Histomorphometry Study in Postmenopausal Women With Low Bone Mass or Osteoporosis Previously Treated With Denosumab Completed
  44. Phase 1 A Multiple-Dose Study to Evaluate Skin Irritation and Sensitization of Teriparatide Administered Transdermally in Healthy Postmenopausal Women Completed

Showing the 50 most-cited and recently-updated of 60 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Osteoporosis

Related studies from across the Osteoporosis family.

CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis
Allergy & Immunology Sys. Review
CD8+ T cells and associated signaling pathways influence osteoclast formation and osteoblast differentiation in osteoporosis Immune Cells and Signaling Pathways Influence Bone Health in Osteoporosis
This narrative review synthesizes the role of CD8+ T cells and related cytokines like IFN-gamma, CCL5, and IL-33 in bone metabolism. The aut…
New research highlights how specific immune cells and signaling pathways may play a dual role in protecting or promoting bone loss in osteop…
Novel osteoporosis therapies targeting osteoclast fusion and polarization show promise beyond bisphosphonates
Drug Pipeline Sys. Review
Novel osteoporosis therapies targeting osteoclast fusion and polarization show promise beyond bisphosphonates New osteoporosis treatments target bone-eating cells more safely
This narrative review examines emerging therapeutic strategies that target osteoclast fusion and polarization, including DC-STAMP/OC-STAMP n…
Future osteoporosis drugs may work by blocking the fusion of bone-destroying cells, offering a safer alternative to current treatments.
Physical exercise therapy may support osteosarcopenia management in elderly patients according to this narrative review
Geriatrics & Aging Sys. Review
Physical exercise therapy may support osteosarcopenia management in elderly patients according to this narrative review Exercise may help fight bone and muscle loss in aging
This narrative review discusses physical exercise therapy for osteosarcopenia in the elderly population. The authors outline potential benef…
A new review suggests physical exercise could slow bone and muscle loss in older adults with osteosarcopenia.
Network meta-analysis reveals optimal aerobic exercise frequency and intensity for improving bone mineral density in osteoporosis patients
Diabetes & Endocrinology Meta-analysis
Network meta-analysis reveals optimal aerobic exercise frequency and intensity for improving bone mineral density in osteoporosis patients Network meta-analysis finds aerobic exercise improves bone density in osteoporosis patients
A comprehensive network meta-analysis of 2,183 participants demonstrates that aerobic exercise significantly boosts bone mineral density acr…
A network meta-analysis of 2,183 participants shows aerobic exercise improves bone density better than control, with specific intensity and …
Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes
Orthopedics & Sports Medicine Sys. Review
Drug-induced osteoporosis mechanisms and gut microbiota links remain largely unresolved for most medication classes Many common medicines might change gut bacteria and affect bone strength in older adults
This narrative review examines the association between medications such as glucocorticoids and aromatase inhibitors and gut microbiota alter…
Some drugs like antidepressants and seizure medicines can alter gut bacteria. Scientists are still studying if these changes hurt bones or c…
Gut microbiome metabolites regulate bone health via SCFAs, bile acids, and tryptophan pathways
Orthopedics & Sports Medicine Sys. Review
Gut microbiome metabolites regulate bone health via SCFAs, bile acids, and tryptophan pathways Multi-omics approaches reveal new links between gut microbes and bone health
This narrative review synthesizes evidence that gut microbiome metabolites—SCFAs, bile acids, and tryptophan derivatives—regulate bone remod…
A narrative review suggests gut microbes may influence bone conditions like osteoporosis and osteoarthritis through specific metabolic pathw…
Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis
Drug Pipeline Sys. Review
Narrative review on polysaccharide metabolites from kidney-tonifying TCM for osteoporosis Chinese Medicine Compounds Show Promise for Osteoporosis
This narrative review synthesizes preclinical evidence on polysaccharide metabolites from kidney-tonifying traditional Chinese medicine for …
A review of kidney-tonifying Chinese medicine compounds suggests they may help treat osteoporosis, but human trials are needed.
Systematic review and meta-analysis of Salvia miltiorrhiza for osteoporosis in animal models
Drug Pipeline Meta-analysis
Systematic review and meta-analysis of Salvia miltiorrhiza for osteoporosis in animal models Lab tests show Salvia miltiorrhiza helps bones grow stronger in animal studies
This systematic review and meta-analysis of 24 animal studies found that Salvia miltiorrhiza-derived interventions significantly improved bo…
A review of twenty-four animal studies found that Salvia miltiorrhiza treatments significantly improved bone density and strength. These lab…
Narrative review on gut-bone axis biomaterials for osteoporosis therapy
Orthopedics & Sports Medicine Sys. Review
Narrative review on gut-bone axis biomaterials for osteoporosis therapy New materials help treat bone loss by talking to the gut bacteria inside the body
This narrative review synthesizes theoretical guidance on gut microbiota modulation and functional biomaterials for osteoporosis. It highlig…
Scientists are testing special materials that can change gut bacteria to help heal weak bones. These new tools might stop bone loss and redu…
Narrative review examines Chinese botanical drugs for osteoporosis without reported clinical data
Drug Pipeline Sys. Review
Narrative review examines Chinese botanical drugs for osteoporosis without reported clinical data Chinese botanical drugs show promise for osteoporosis but evidence remains limited
This narrative review discusses the use of Chinese botanical drugs for osteoporosis. The authors note that key details such as population, s…
A review suggests Chinese botanical drugs may help with osteoporosis, though more research is needed to confirm their safety and effectivene…
Review of senescence-associated secretory phenotype in aging osteoarthritis and disc degeneration
Geriatrics & Aging Sys. Review
Review of senescence-associated secretory phenotype in aging osteoarthritis and disc degeneration Aging cells release signals that may worsen bone and joint disease in older adults
This narrative review examines the senescence-associated secretory phenotype (SASP) in aging populations with osteoarthritis, intervertebral…
A review suggests aging cell signals could drive bone and joint problems. This insight helps doctors understand why these conditions worsen …
Network meta-analysis compares osteoporosis drugs for bone density in men
Diabetes & Endocrinology Meta-analysis
Network meta-analysis compares osteoporosis drugs for bone density in men Men's Osteoporosis Drugs Work Better on Spines Than Hips
This network meta-analysis of 4,409 men with primary osteoporosis compared six medications. It found significant improvements in bone minera…
• Abaloparatide and teriparatide boost spine bone density most • Helps men with weak bones avoid fractures • Not yet proven to prevent actua…